Skip to main content Skip to section navigation Skip to footer
News Careers Contact us Medical Information
Immunocore Holdings plc
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Compliance and Transparency
  • Pipeline & Portfolio
    • Pipeline
    • Our Therapies
  • Science
    • Overview
    • Publications
  • Clinical Trials
  • Investors
    • Overview
    • News
    • Events & Presentations
    • Stock Info
    • Financials & Filings
    • Governance
    • IR Resources
  • News
  • Careers
  • Contact us
  • Medical Information

Events

Investors

Investors

  • Overview
  • News
    • Press Releases
    • Email Alerts
  • Events & Presentations
    • Events
    • Presentations
  • Stock Info
    • Quote and Chart
    • Historical Performance
    • Analyst Coverage
  • Financials & Filings
    • Financial Results
    • SEC Filings
    • Annual Reports
    • Email Alerts
  • Governance
    • Overview
    • Governance Documents
    • Management Team
    • Board of Directors
    • Board Committees
  • IR Resources
    • Investor FAQs
    • Email Alerts
    • Contacts

  • Events & Presentations

  • Events
  • Presentations

Q4 2023 Earnings Call

Feb 28, 2024 8:00 am EST
Earnings Release
HTML PDF
10-K Filing
HTML PDF
XBRL
ZIP
Annual Report
PDF
  • emailEmail Alerts
  • contact_pageContacts
  • rss_feedRSS News Feed
  • account_treeSitemap
Immunocore Holdings plc
  • Visit us on Linkedin
  • Visit us on Youtube
©2024 Immunocore Holdings plc. All Rights Reserved.
Disclaimer Sitemap Compliance and Transparency Terms and Conditions
Privacy and Social Media Guidelines Cookies Payments and Disclosures
Clinical Trials Gender Pay Report Modern Slavery Statement Manage Cookie Preferences

This is Immunocore's global website, intended for visitors seeking information on Immunocore's worldwide business.

If you are a medical professional and would like further information about Immunocore, our clinical research or clinical trials, please send an email to medical.information@immunocore.com (US) or medinfo.eu@immunocore.com (outside of US).

CM-GL-TAX-2400001
Date of production: April 2024